<SEC-DOCUMENT>0001437749-18-000301-index.html : 20180105
<SEC-HEADER>0001437749-18-000301.hdr.sgml : 20180105
<ACCEPTANCE-DATETIME>20180105092012
ACCESSION NUMBER:		0001437749-18-000301
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20180103
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20180105
DATE AS OF CHANGE:		20180105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aviragen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		18512195

	BUSINESS ADDRESS:	
		STREET 1:		2500 NORTHWINDS PARKWAY, SUITE 100
		CITY:			ALPHARETTA
		STATE:			2Q
		ZIP:			30009
		BUSINESS PHONE:		301-770-3099

	MAIL ADDRESS:	
		STREET 1:		2500 NORTHWINDS PARKWAY, SUITE 100
		CITY:			ALPHARETTA
		STATE:			2Q
		ZIP:			30009

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI  BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20020304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>avir20180104_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: avir20180104_8k.htm

</DOCUMENT>
</SEC-DOCUMENT>